Skip to main content
OpenTrials

Clinical trial condition

Rectal Neoplasms

Explore clinical trials studying Rectal Neoplasms. Study availability and eligibility vary by location and protocol.

180 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Rectal Neoplasms trial results

Active, not recruiting

Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus

NCT04046133

Conditions
Anal Cancer Stage III A, Anal Cancer Stage III B, Anus Diseases, +12 more
Locations
  • Oslo University Hospital Oslo, Norway
  • Aberdeen Royal Informary Aberdeen, Scotland, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
View Trial Details
Active, not recruiting

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

NCT06866574

Conditions
Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +34 more
Locations
  • Fujian Provincial Center for Disease Control and Prevention Fuzhou, Fujian, China
  • Sichuan Provincial Center for Disease Control and Prevention Chengdu, Sichuan, China
  • Yunnan Provincial Center for Disease Control and Prevention Kunming, Yunnan, China
  • Zhejiang Provincial Center for Disease Control and Prevention Hangzhou, Zhejiang, China
View Trial Details
Active, not recruiting

Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.

NCT04719988

Conditions
Anus Diseases, Anus Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Centre Hospitalier Universitaire de Besançon Besançon, France
  • Centre georges-François Leclerc Dijon, France
  • Hôpital Franco-Britannique Levallois-Perret, France
  • Centre Léon Bérard Lyon, France
View Trial Details
Active, not recruiting

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

NCT06465914

Conditions
AIN1, AIN2, AIN3, +45 more
Locations
  • Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Nanning, Guangxi, China
  • Hunan Center for Disease Control and Prevention Changsha, Hunan, China
  • Shanxi Provincial Disease for Control and Prevention Taiyuan, Shanxi, China
  • Sichuan Center for Disease Control and Prevention Chengdu, Sichuan, China
View Trial Details

Related conditions